Overview
Beta-Amyloid (1-15) is a crucial peptide sequence that plays a significant role in neurological research. As a truncated form of the beta-amyloid protein, this peptide is instrumental in studies related to Alzheimer’s disease and other neurodegenerative disorders. Understanding its role can enhance the development of therapeutic interventions and diagnostic assays. When you invest in our high-quality Beta-Amyloid (1-15) peptide, you’re choosing a product derived from the human sequence, ensuring authenticity and reliability for your experiments.
Key Features
- Truncated beta-amyloid peptide sequence (1-15)
- Human-derived for optimal relevance in research
- Purity guaranteed for consistent results
- Available in 1 mg quantities
- Ideal for assays and diagnostic applications
Specifications
| Product Name | Beta-Amyloid (1-15) |
|---|---|
| Category | Peptides |
| Quantity | 1 mg |
| Sequence | Human |
FAQ
What is the significance of Beta-Amyloid (1-15) in research?
Beta-Amyloid (1-15) is vital for studying Alzheimer’s disease, as it helps researchers understand the formation and aggregation of amyloid plaques, which are hallmarks of the disease.
How pure is the Beta-Amyloid (1-15) peptide?
We guarantee high purity for our Beta-Amyloid (1-15), which is essential for reliable experimental results. Each batch is tested to ensure it meets strict quality standards.
Can Beta-Amyloid (1-15) be used in therapeutic applications?
This peptide is primarily used for research and diagnostic purposes, helping scientists explore potential therapeutic strategies targeting Alzheimer’s disease and related conditions.
When you’re ready to advance your research, consider adding Beta-Amyloid (1-15) to your toolkit. Additionally, explore our wide range of peptides and other related products like PKG Substrate or Autocamtide-2 for comprehensive studies.




Reviews
There are no reviews yet.